LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma
Clinical trial NCT00085150 · COMPLETED
Trial details
- NCT number
- NCT00085150
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.